Stockreport

INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx
PDF PLYMOUTH MEETING, Pa., Feb. 7, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat an [Read more]